Frailty Among Older Adults With Acute Myocardial Infarction and Outcomes From Percutaneous Coronary Interventions.
Administrative Claims, Healthcare
Age Factors
Aged
Aged, 80 and over
Databases, Factual
Female
Frail Elderly
Frailty
/ diagnosis
Geriatric Assessment
Health Status
Hospital Mortality
Humans
Male
Myocardial Infarction
/ diagnosis
Percutaneous Coronary Intervention
/ adverse effects
Prevalence
Risk Factors
Time Factors
Treatment Outcome
United States
/ epidemiology
administrative claims
cardiovascular disease
elderly
frailty
myocardial infarction
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
03 09 2019
03 09 2019
Historique:
entrez:
3
9
2019
pubmed:
3
9
2019
medline:
15
9
2020
Statut:
ppublish
Résumé
Background Frailty is a predictor of adverse outcomes after acute myocardial infarction (AMI). Methods and Results We estimated the prevalence of frailty among adults age ≥75 years admitted with AMI and examined the relationship between frailty, interventions, and mortality. We used the Premier Healthcare Database to identify older adults with primary diagnoses of AMI. We classified individuals as frail or not using the validated Claims-based Frailty Index. We described patients' characteristics and receipt of percutaneous coronary intervention stratified by frailty status. The primary outcome was hospital mortality. From 2000 to 2016, we identified 469 390 encounters for older patients admitted with AMI. The median age was 82 years, 53% were women, and 75% were white. The prevalence of frailty was 19%. Frail patients were less likely to receive percutaneous coronary intervention than nonfrail (15% versus 33%, P<0.001) and much less likely to receive coronary artery bypass surgery (1% versus 9%, P<0.001). There were far fewer interventions in individuals over age 85 years. Frailty was associated with higher mortality during AMI admission (unadjusted odds ratio [OR] 1.43, CI 1.39-1.46). While there was a differential benefit of the interventions because of frailty, frail patients had reduced hospital mortality with percutaneous coronary intervention (frail: OR 0.59, CI 0.55-0.63; nonfrail: OR 0.49, CI 0.47-0.50, P for interaction <0.001) and with coronary artery bypass surgery (frail: OR 0.77, CI 0.65-0.93; nonfrail: OR 0.74, CI 0.71-0.77, P for interaction <0.001) relative to no intervention. Conclusions In the United States, frailty is common among older patients admitted with AMI. While these vulnerable patients are at an increased risk for mortality, judicial use of revascularization with percutaneous coronary intervention in frail older patients still confers immediate survival benefit.
Identifiants
pubmed: 31475601
doi: 10.1161/JAHA.119.013686
pmc: PMC6755849
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e013686Subventions
Organisme : NIA NIH HHS
ID : P30 AG021334
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024827
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG049036
Pays : United States
Références
Am J Cardiol. 2012 Jun 1;109(11):1569-75
pubmed: 22440119
Lancet. 2016 Mar 12;387(10023):1057-1065
pubmed: 26794722
Circ Cardiovasc Interv. 2017 Sep;10(9):
pubmed: 28916608
Circulation. 2011 Nov 29;124(22):2397-404
pubmed: 22064593
Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):508-16
pubmed: 26307132
Circulation. 2007 May 15;115(19):2549-69
pubmed: 17502590
J Am Coll Cardiol. 2014 Mar 4;63(8):747-62
pubmed: 24291279
Arch Gerontol Geriatr. 2015 Jul-Aug;61(1):1-7
pubmed: 25921097
Am J Med. 2011 Jul;124(7):630-5
pubmed: 21601821
Med Care. 2017 Jul;55(7):716-722
pubmed: 28437320
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
JACC Cardiovasc Interv. 2011 Sep;4(9):1020-7
pubmed: 21939943
Am J Epidemiol. 2017 Sep 15;186(6):745-747
pubmed: 28938711
Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):496-502
pubmed: 21878670
Circulation. 2007 Sep 25;116(13):1465-72
pubmed: 17785621
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364
J Am Geriatr Soc. 2006 Nov;54(11):1674-81
pubmed: 17087693
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Circulation. 2007 May 15;115(19):2570-89
pubmed: 17502591
J Am Heart Assoc. 2016 Jul 13;5(7):
pubmed: 27413043
Mayo Clin Proc. 2015 May;90(5):597-605
pubmed: 25794453
J Am Coll Cardiol. 2010 May 4;55(18):1923-32
pubmed: 20430263
J Geriatr Cardiol. 2015 Sep;12(5):459-64
pubmed: 26512234
J Am Coll Cardiol. 2017 Aug 8;70(6):689-700
pubmed: 28693934
J Am Heart Assoc. 2019 Sep 3;8(17):e013686
pubmed: 31475601